OTCPK:MHCC

Stock Analysis Report

Executive Summary

Millennium Healthcare, Inc. operates as a medical device and healthcare support and services company in the United States.

Snowflake

Fundamentals

Adequate balance sheet with weak fundamentals.

Risks

  • Millennium Healthcare has significant price volatility in the past 3 months.
  • Millennium Healthcare's last earnings update was 1023 days ago.
  • Millennium Healthcare is not covered by any analysts.

Similar Companies

Share Price & News

How has Millennium Healthcare's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

MHCC

-0.7%

US Healthcare

-0.5%

US Market


1 Year Return

0%

MHCC

-9.3%

US Healthcare

0.9%

US Market

MHCC outperformed the Healthcare industry which returned -9.2% over the past year.

MHCC matched the United States of America Market (0.7%) over the past year.


Share holder returns

MHCCIndustryMarket
7 Day0%-0.7%-0.5%
30 Day-50.0%1.6%4.8%
90 Day0%-0.6%2.3%
1 Year0%0%-7.9%-9.3%3.1%0.9%
3 Year-66.7%-66.7%29.5%24.3%45.5%36.0%
5 Year-100.0%-100.0%65.6%55.8%62.5%44.7%

Price Volatility Vs. Market

How volatile is Millennium Healthcare's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Millennium Healthcare undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether Millennium Healthcare is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Millennium Healthcare has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Examine Millennium Healthcare's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Millennium Healthcare regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Millennium Healthcare expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

11.1%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Millennium Healthcare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Millennium Healthcare performed over the past 5 years?

0.1%

Historical Healthcare annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Millennium Healthcare has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

Financial Health

How is Millennium Healthcare's financial position?


In this section we usually analyse Millennium Healthcare's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Millennium Healthcare has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of MHCC’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when Millennium Healthcare's financial data was last updated here.
  • Explore more healthy companies in the Healthcare industry.

Dividend

What is Millennium Healthcare's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Millennium Healthcare's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Millennium Healthcare's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Millennium Healthcare has not reported any payouts.

Unable to verify if Millennium Healthcare's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Millennium Healthcare has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Millennium Healthcare's salary, the management and board of directors tenure and is there insider trading?

3.9yrs

Average management tenure


CEO

Lou Resweber (57yo)

3.5yrs

Tenure

0

Mr. Louis J. Resweber, also known as Lou, is Chairman, President, Chief Executive Officer of NuLife Sciences, Inc. since October 9, 2018. Mr. Resweber has been Chairman of the Board and Chief Executive Off ...


Management Age and Tenure

3.9yrs

Average Tenure

52yo

Average Age

The tenure for the Millennium Healthcare management team is about average.


Board Age and Tenure

7.8yrs

Average Tenure

53yo

Average Age

The tenure for the Millennium Healthcare board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Management Team

  • Martin Schacker (62yo)

    Executive

    • Tenure: 0yrs
  • Edward Joyce (51yo)

    Member of Advisory Board and President of Millennium Medical Devices Llc

    • Tenure: 7.5yrs
  • Chris Amandola (48yo)

    President and Director

    • Tenure: 8.3yrs
    • Compensation: US$180.00k
  • Dominick Sartorio (53yo)

    Executive Chairman of the Board

    • Tenure: 4.7yrs
    • Compensation: US$742.50k
  • Anthony Urbano (49yo)

    Chief Financial Officer and Director

    • Tenure: 8.3yrs
    • Compensation: US$275.00k
  • Manuel Vazquez

    Senior Vice President of Technology

    • Tenure: 3.9yrs
  • Darrell Contreras

    Chief Compliance Officer

    • Tenure: 3.8yrs
  • Rami Ben-Joseph

    Senior Vice President of Health Outcomes Research

    • Tenure: 3.8yrs
  • Lou Resweber (57yo)

    Chief Executive Officer and Director

    • Tenure: 3.5yrs
  • Jake Wengroff

    Investor Relations Manager

    • Tenure: 0yrs

Board Members

  • Harold Paul (71yo)

    Director

    • Tenure: 20.7yrs
  • John Milcetich (57yo)

    Director

    • Tenure: 0yrs
  • Marc Pergament

    Director

    • Tenure: 7.1yrs
  • Edward Joyce (51yo)

    Member of Advisory Board and President of Millennium Medical Devices Llc

    • Tenure: 7.5yrs
  • Marc Sherman

    Member of Advisory Board

    • Tenure: 7.8yrs
  • Chris Amandola (48yo)

    President and Director

    • Tenure: 8.3yrs
    • Compensation: US$180.00k
  • Elias Zias

    Member of Advisory Board

    • Tenure: 7.8yrs
  • Dominick Sartorio (53yo)

    Executive Chairman of the Board

    • Tenure: 4.7yrs
    • Compensation: US$742.50k
  • Anthony Urbano (49yo)

    Chief Financial Officer and Director

    • Tenure: 8.3yrs
    • Compensation: US$275.00k
  • Lou Resweber (57yo)

    Chief Executive Officer and Director

    • Tenure: 3.5yrs

Company Information

Millennium Healthcare, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Millennium Healthcare, Inc.
  • Ticker: MHCC
  • Exchange: OTCPK
  • Founded: 1994
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$171.438k
  • Shares outstanding: 1.71b
  • Website: https://www.millenniumhcs.com

Number of Employees


Location

  • Millennium Healthcare, Inc.
  • 445 Broad Hollow Road
  • Suite 25
  • Melville
  • New York
  • 11747
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MHCCOTCPK (Pink Sheets LLC)YesCommon StockUSUSDJan 1995

Biography

Millennium Healthcare, Inc. operates as a medical device and healthcare support and services company in the United States. It operates in three segments: Coding, Vascular, and Devices. The company purchase ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/24 00:17
End of Day Share Price2019/09/16 00:00
Earnings2015/12/31
Annual Earnings2015/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.